{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T07:14:17Z","timestamp":1793517257432,"version":"4.5.0"},"reference-count":193,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T00:00:00Z","timestamp":1587513600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T00:00:00Z","timestamp":1587513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["P30-DK090728"],"award-info":[{"award-number":["P30-DK090728"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Diagn Ther"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s40291-020-00467-6","type":"journal-article","created":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T07:02:43Z","timestamp":1587538963000},"page":"375-396","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Improving Molecular Therapy in the Kidney"],"prefix":"10.1007","volume":"24","author":[{"given":"Jeffrey D.","family":"Rubin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Barry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,22]]},"reference":[{"issue":"7","key":"467_CR1","doi-asserted-by":"crossref","first-page":"e0158765","DOI":"10.1371\/journal.pone.0158765","volume":"11","author":"NR Hill","year":"2016","unstructured":"Hill NR, Fatoba ST, Oke JL, Hirst JA, O\u2019Callaghan CA, Lasserson DS, et al. Global prevalence of chronic kidney disease\u2014a systematic review and meta-analysis. PLoS One. 2016;11(7):e0158765.","journal-title":"PLoS One."},{"issue":"9722","key":"467_CR2","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0140-6736(10)60236-X","volume":"375","author":"F Hildebrandt","year":"2010","unstructured":"Hildebrandt F. Genetic kidney diseases. Lancet. 2010;375(9722):1287\u201395.","journal-title":"Lancet."},{"issue":"2","key":"467_CR3","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2174\/157339631002140513101755","volume":"10","author":"JC Leung","year":"2014","unstructured":"Leung JC. Inherited renal diseases. Curr Pediatr Rev. 2014;10(2):95\u2013100.","journal-title":"Curr Pediatr Rev."},{"key":"467_CR4","first-page":"739","volume-title":"Glomerular filtration and renal blood flow. Medical physiology","author":"WB Boron","year":"2017","unstructured":"Boron WB, Emile S. Glomerular filtration and renal blood flow. Medical physiology. 3rd ed. Amsterdam: Elsevier; 2017. p. 739\u201353.","edition":"3"},{"issue":"1","key":"467_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-5347(17)66118-4","volume":"80","author":"JJ Murphy","year":"1958","unstructured":"Murphy JJ, Myint MK, Rattner WH, Klaus R, Shallow J. The lymphatic system of the kidney. J Urol. 1958;80(1):1\u20136.","journal-title":"J Urol."},{"issue":"3","key":"467_CR6","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1113\/jphysiol.1971.sp009438","volume":"214","author":"GH McIntosh","year":"1971","unstructured":"McIntosh GH, Morris B. The lymphatics of the kidney and the formation of renal lymph. J Physiol. 1971;214(3):365\u201376.","journal-title":"J Physiol."},{"issue":"1\u20132","key":"467_CR7","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ymgme.2003.08.016","volume":"80","author":"SE Raper","year":"2003","unstructured":"Raper SE, Chirmule N, Lee FS, Wivel NA, Bagg A, Gao GP, et al. Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol Genet Metab. 2003;80(1\u20132):148\u201358.","journal-title":"Mol Genet Metab"},{"issue":"5","key":"467_CR8","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/1074-7613(94)90074-4","volume":"1","author":"Y Yang","year":"1994","unstructured":"Yang Y, Ertl HC, Wilson JM. MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity. 1994;1(5):433\u201342.","journal-title":"Immunity."},{"issue":"9","key":"467_CR9","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1089\/hum.2009.028","volume":"20","author":"K Doronin","year":"2009","unstructured":"Doronin K, Shashkova EV, May SM, Hofherr SE, Barry MA. Chemical modification with high molecular weight polyethylene glycol reduces transduction of hepatocytes and increases efficacy of intravenously delivered oncolytic adenovirus. Hum Gene Ther. 2009;20(9):975\u201388.","journal-title":"Hum Gene Ther."},{"issue":"9","key":"467_CR10","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.2174\/138920112800958823","volume":"13","author":"MA Barry","year":"2012","unstructured":"Barry MA, Weaver EA, Chen CY. Mining the adenovirus \u201cvirome\u201d for systemic oncolytics. Curr Pharm Biotechnol. 2012;13(9):1804\u20138.","journal-title":"Curr Pharm Biotechnol."},{"issue":"11","key":"467_CR11","doi-asserted-by":"crossref","first-page":"8798","DOI":"10.1128\/JVI.71.11.8798-8807.1997","volume":"71","author":"A Lieber","year":"1997","unstructured":"Lieber A, He CY, Meuse L, Schowalter D, Kirillova I, Winther B, et al. The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors. J Virol. 1997;71(11):8798\u2013807.","journal-title":"J Virol."},{"issue":"1","key":"467_CR12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1089\/hum.1997.8.1-37","volume":"8","author":"S Worgall","year":"1997","unstructured":"Worgall S, Wolff G, Falck-Pedersen E, Crystal RG. Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration. Hum Gene Ther. 1997;8(1):37\u201344.","journal-title":"Hum Gene Ther."},{"issue":"4","key":"467_CR13","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/ki.1997.421","volume":"52","author":"G Zhu","year":"1997","unstructured":"Zhu G, Nicolson AG, Zheng XX, Strom TB, Sukhatme VP. Adenovirus-mediated beta-galactosidase gene delivery to the liver leads to protein deposition in kidney glomeruli. Kidney Int. 1997;52(4):992\u20139.","journal-title":"Kidney Int."},{"issue":"4","key":"467_CR14","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1089\/10430340050015806","volume":"11","author":"X Ye","year":"2000","unstructured":"Ye X, Jerebtsova M, Ray PE. Liver bypass significantly increases the transduction efficiency of recombinant adenoviral vectors in the lung, intestine, and kidney. Hum Gene Ther. 2000;11(4):621\u20137.","journal-title":"Hum Gene Ther."},{"issue":"4","key":"467_CR15","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1038\/ki.1994.162","volume":"45","author":"P Moullier","year":"1994","unstructured":"Moullier P, Friedlander G, Calise D, Ronco P, Perricaudet M, Ferry N. Adenoviral-mediated gene transfer to renal tubular cells in vivo. Kidney Int. 1994;45(4):1220\u20135.","journal-title":"Kidney Int."},{"issue":"1","key":"467_CR16","first-page":"21","volume":"3","author":"P Heikkila","year":"1996","unstructured":"Heikkila P, Parpala T, Lukkarinen O, Weber M, Tryggvason K. Adenovirus-mediated gene transfer into kidney glomeruli using an ex vivo and in vivo kidney perfusion system\u2014first steps towards gene therapy of Alport syndrome. Gene Ther. 1996;3(1):21\u20137.","journal-title":"Gene Ther."},{"issue":"2","key":"467_CR17","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/(SICI)1521-2254(199903\/04)1:2<103::AID-JGM16>3.0.CO;2-O","volume":"1","author":"GA McDonald","year":"1999","unstructured":"McDonald GA, Zhu G, Li Y, Kovesdi I, Wickham TJ, Sukhatme VP. Efficient adenoviral gene transfer to kidney cortical vasculature utilizing a fiber modified vector. J Gene Med. 1999;1(2):103\u201310.","journal-title":"J Gene Med."},{"issue":"2","key":"467_CR18","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1089\/104303401750061203","volume":"12","author":"X Ye","year":"2001","unstructured":"Ye X, Liu X, Li Z, Ray PE. Efficient gene transfer to rat renal glomeruli with recombinant adenoviral vectors. Hum Gene Ther. 2001;12(2):141\u20138.","journal-title":"Hum Gene Ther."},{"issue":"3","key":"467_CR19","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/ndt\/16.3.608","volume":"16","author":"V Chetboul","year":"2001","unstructured":"Chetboul V, Klonjkowski B, Lefebvre HP, Desvaux D, Laroute V, Rosenberg D, et al. Short-term efficiency and safety of gene delivery into canine kidneys. Nephrol Dial Transplant. 2001;16(3):608\u201314.","journal-title":"Nephrol Dial Transplant."},{"issue":"7","key":"467_CR20","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/sj.gt.3301926","volume":"10","author":"YK Choi","year":"2003","unstructured":"Choi YK, Kim YJ, Park HS, Choi K, Paik SG, Lee YI, et al. Suppression of glomerulosclerosis by adenovirus-mediated IL-10 expression in the kidney. Gene Ther. 2003;10(7):559\u201368.","journal-title":"Gene Ther."},{"issue":"7","key":"467_CR21","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/ndt\/gfh783","volume":"20","author":"J Fujishiro","year":"2005","unstructured":"Fujishiro J, Takeda S, Takeno Y, Takeuchi K, Ogata Y, Takahashi M, et al. Gene transfer to the rat kidney in vivo and ex vivo using an adenovirus vector: factors influencing transgene expression. Nephrol Dial Transplant. 2005;20(7):1385\u201391.","journal-title":"Nephrol Dial Transplant."},{"issue":"11","key":"467_CR22","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/sj.gt.3301342","volume":"8","author":"P Heikkila","year":"2001","unstructured":"Heikkila P, Tibell A, Morita T, Chen Y, Wu G, Sado Y, et al. Adenovirus-mediated transfer of type IV collagen alpha5 chain cDNA into swine kidney in vivo: deposition of the protein into the glomerular basement membrane. Gene Ther. 2001;8(11):882\u201390.","journal-title":"Gene Ther."},{"key":"467_CR23","doi-asserted-by":"crossref","unstructured":"Rubin J, Nguyen TV, Allen K, Ayasoufi K, Barry MA. Comparison of gene delivery to the kidney by adenovirus, adeno-associated virus, and lentiviral vectors after intravenous and direct kidney injections. Hum Gene Ther. 2019.","DOI":"10.1089\/hum.2019.127"},{"issue":"3","key":"467_CR24","doi-asserted-by":"crossref","first-page":"e0168638","DOI":"10.1371\/journal.pone.0168638","volume":"12","author":"S Watanabe","year":"2017","unstructured":"Watanabe S, Ogasawara T, Tamura Y, Saito T, Ikeda T, Suzuki N, et al. Targeting gene expression to specific cells of kidney tubules in vivo, using adenoviral promoter fragments. PLoS One. 2017;12(3):e0168638.","journal-title":"PLoS One."},{"issue":"12","key":"467_CR25","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1089\/hum.2004.15.1167","volume":"15","author":"JJ Rux","year":"2004","unstructured":"Rux JJ, Burnett RM. Adenovirus structure. Hum Gene Ther. 2004;15(12):1167\u201376.","journal-title":"Hum Gene Ther."},{"issue":"12","key":"467_CR26","doi-asserted-by":"crossref","first-page":"7478","DOI":"10.1128\/JVI.79.12.7478-7491.2005","volume":"79","author":"DM Shayakhmetov","year":"2005","unstructured":"Shayakhmetov DM, Gaggar A, Ni S, Li ZY, Lieber A. Adenovirus binding to blood factors results in liver cell infection and hepatotoxicity. J Virol. 2005;79(12):7478\u201391.","journal-title":"J Virol."},{"issue":"8","key":"467_CR27","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1182\/blood-2006-04-008532","volume":"108","author":"AL Parker","year":"2006","unstructured":"Parker AL, Waddington SN, Nicol CG, Shayakhmetov DM, Buckley SM, Denby L, et al. Multiple vitamin K-dependent coagulation zymogens promote adenovirus-mediated gene delivery to hepatocytes. Blood. 2006;108(8):2554\u201361.","journal-title":"Blood."},{"issue":"23","key":"467_CR28","doi-asserted-by":"crossref","first-page":"11705","DOI":"10.1128\/JVI.01320-08","volume":"82","author":"Z Xu","year":"2008","unstructured":"Xu Z, Tian J, Smith JS, Byrnes AP. Clearance of adenovirus by Kupffer cells is mediated by scavenger receptors, natural antibodies, and complement. J Virol. 2008;82(23):11705\u201313.","journal-title":"J Virol."},{"issue":"3","key":"467_CR29","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1128\/JVI.72.3.1844-1852.1998","volume":"72","author":"V Krasnykh","year":"1998","unstructured":"Krasnykh V, Dmitriev I, Mikheeva G, Miller CR, Belousova N, Curiel DT. Characterization of an adenovirus vector containing a heterologous peptide epitope in the HI loop of the fiber knob. J Virol. 1998;72(3):1844\u201352.","journal-title":"J Virol."},{"issue":"12","key":"467_CR30","doi-asserted-by":"crossref","first-page":"9706","DOI":"10.1128\/JVI.72.12.9706-9713.1998","volume":"72","author":"I Dmitriev","year":"1998","unstructured":"Dmitriev I, Krasnykh V, Miller CR, Wang M, Kashentseva E, Mikheeva G, et al. An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism. J Virol. 1998;72(12):9706\u201313.","journal-title":"J Virol."},{"issue":"1","key":"467_CR31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0304-4165(01)00194-5","volume":"1568","author":"N Koizumi","year":"2001","unstructured":"Koizumi N, Mizuguchi H, Hosono T, Ishii-Watabe A, Uchida E, Utoguchi N, et al. Efficient gene transfer by fiber-mutant adenoviral vectors containing RGD peptide. Biochim Biophys Acta. 2001;1568(1):13\u201320.","journal-title":"Biochim Biophys Acta."},{"issue":"9","key":"467_CR32","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/sj.gt.3301453","volume":"8","author":"H Mizuguchi","year":"2001","unstructured":"Mizuguchi H, Koizumi N, Hosono T, Utoguchi N, Watanabe Y, Kay MA, et al. A simplified system for constructing recombinant adenoviral vectors containing heterologous peptides in the HI loop of their fiber knob. Gene Ther. 2001;8(9):730\u20135.","journal-title":"Gene Ther."},{"issue":"11","key":"467_CR33","doi-asserted-by":"crossref","first-page":"8221","DOI":"10.1128\/JVI.71.11.8221-8229.1997","volume":"71","author":"TJ Wickham","year":"1997","unstructured":"Wickham TJ, Tzeng E, Shears LL 2nd, Roelvink PW, Li Y, Lee GM, et al. Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins. J Virol. 1997;71(11):8221\u20139.","journal-title":"J Virol."},{"issue":"9","key":"467_CR34","first-page":"660","volume":"2","author":"SI Michael","year":"1995","unstructured":"Michael SI, Hong JS, Curiel DT, Engler JA. Addition of a short peptide ligand to the adenovirus fiber protein. Gene Ther. 1995;2(9):660\u20138.","journal-title":"Gene Ther."},{"issue":"3","key":"467_CR35","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.ymthe.2005.05.008","volume":"12","author":"SA Nicklin","year":"2005","unstructured":"Nicklin SA, Wu E, Nemerow GR, Baker AH. The influence of adenovirus fiber structure and function on vector development for gene therapy. Mol Ther. 2005;12(3):384\u201393.","journal-title":"Mol Ther."},{"issue":"21","key":"467_CR36","doi-asserted-by":"crossref","first-page":"13667","DOI":"10.1128\/JVI.79.21.13667-13672.2005","volume":"79","author":"D Ghosh","year":"2005","unstructured":"Ghosh D, Barry MA. Selection of muscle-binding peptides from context-specific peptide-presenting phage libraries for adenoviral vector targeting. J Virol. 2005;79(21):13667\u201372.","journal-title":"J Virol."},{"issue":"3","key":"467_CR37","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nm0396-299","volume":"2","author":"MA Barry","year":"1996","unstructured":"Barry MA, Dower WJ, Johnston SA. Toward cell-targeting gene therapy vectors: selection of cell-binding peptides from random peptide-presenting phage libraries. Nat Med. 1996;2(3):299\u2013305.","journal-title":"Nat Med."},{"issue":"23","key":"467_CR38","first-page":"8","volume":"19","author":"CH Wu","year":"2016","unstructured":"Wu CH, Liu IJ, Lu RM, Wu HC. Advancement and applications of peptide phage display technology in biomedical science. J Biomed Sci. 2016;19(23):8.","journal-title":"J Biomed Sci."},{"key":"467_CR39","first-page":"549","volume-title":"Vector targeting strategies for gene therapy","author":"MA Barry","year":"2002","unstructured":"Barry MA, Takahashi S, Parrott MB. Selection of peptides on phage. In: Douglas JaC DT, editor. Vector targeting strategies for gene therapy. Hoboken: Wiley-Liss, Inc.; 2002. p. 549\u201379."},{"issue":"9","key":"467_CR40","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1038\/sj.mt.6300214","volume":"15","author":"L Denby","year":"2007","unstructured":"Denby L, Work LM, Seggern DJ, Wu E, McVey JH, Nicklin SA, et al. Development of renal-targeted vectors through combined in vivo phage display and capsid engineering of adenoviral fibers from serotype 19p. Mol Ther. 2007;15(9):1647\u201354.","journal-title":"Mol Ther."},{"issue":"6","key":"467_CR41","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1089\/hum.2008.108","volume":"20","author":"I Diaconu","year":"2009","unstructured":"Diaconu I, Denby L, Pesonen S, Cerullo V, Bauerschmitz GJ, Guse K, et al. Serotype chimeric and fiber-mutated adenovirus Ad5\/19p-HIT for targeting renal cancer and untargeting the liver. Hum Gene Ther. 2009;20(6):611\u201320.","journal-title":"Hum Gene Ther."},{"issue":"3","key":"467_CR42","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2174\/156652307780859062","volume":"7","author":"SK Campos","year":"2007","unstructured":"Campos SK, Barry MA. Current advances and future challenges in adenoviral vector biology and targeting. Curr Gene Ther. 2007;7(3):189\u2013204.","journal-title":"Curr Gene Ther."},{"issue":"4","key":"467_CR43","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S1525-0016(03)00213-2","volume":"8","author":"MB Parrott","year":"2003","unstructured":"Parrott MB, Adams KE, Mercier GT, Mok H, Campos SK, Barry MA. Metabolically biotinylated adenovirus for cell targeting, ligand screening, and vector purification. Mol Ther. 2003;8(4):688\u2013700.","journal-title":"Mol Ther."},{"issue":"6","key":"467_CR44","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.ymthe.2004.03.006","volume":"9","author":"SK Campos","year":"2004","unstructured":"Campos SK, Parrott MB, Barry MA. Avidin-based targeting and purification of a protein IX-modified, metabolically biotinylated adenoviral vector. Mol Ther. 2004;9(6):942\u201354.","journal-title":"Mol Ther."},{"issue":"2","key":"467_CR45","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.virol.2006.01.032","volume":"349","author":"SK Campos","year":"2006","unstructured":"Campos SK, Barry MA. Comparison of adenovirus fiber, protein IX, and hexon capsomeres as scaffolds for vector purification and cell targeting. Virology. 2006;349(2):453\u201362.","journal-title":"Virology."},{"issue":"1","key":"467_CR46","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S1525-0016(03)00139-4","volume":"8","author":"J Lanciotti","year":"2003","unstructured":"Lanciotti J, Song A, Doukas J, Sosnowski B, Pierce G, Gregory R, et al. Targeting adenoviral vectors using heterofunctional polyethylene glycol FGF2 conjugates. Mol Ther. 2003;8(1):99\u2013107.","journal-title":"Mol Ther."},{"issue":"16","key":"467_CR47","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1089\/10430349950016654","volume":"10","author":"H Romanczuk","year":"1999","unstructured":"Romanczuk H, Galer CE, Zabner J, Barsomian G, Wadsworth SC, O\u2019Riordan CR. Modification of an adenoviral vector with biologically selected peptides: a novel strategy for gene delivery to cells of choice. Hum Gene Ther. 1999;10(16):2615\u201326.","journal-title":"Hum Gene Ther."},{"issue":"17","key":"467_CR48","first-page":"5213","volume":"63","author":"S Takahashi","year":"2003","unstructured":"Takahashi S, Mok H, Parrott MB, Marini FC 3rd, Andreeff M, Brenner MK, et al. Selection of chronic lymphocytic leukemia binding peptides. Cancer Res. 2003;63(17):5213\u20137.","journal-title":"Cancer Res."},{"issue":"3","key":"467_CR49","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1089\/hum.2006.17.314","volume":"17","author":"KM Menezes","year":"2006","unstructured":"Menezes KM, Mok HS, Barry MA. Increased transduction of skeletal muscle cells by fibroblast growth factor-modified adenoviral vectors. Hum Gene Ther. 2006;17(3):314\u201320.","journal-title":"Hum Gene Ther."},{"issue":"8","key":"467_CR50","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1089\/10430349950018021","volume":"10","author":"CR O\u2019Riordan","year":"1999","unstructured":"O\u2019Riordan CR, Lachapelle A, Delgado C, Parkes V, Wadsworth SC, Smith AE, et al. PEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in vitro and in vivo. Hum Gene Ther. 1999;10(8):1349\u201358.","journal-title":"Hum Gene Ther."},{"issue":"1","key":"467_CR51","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ymthe.2004.09.015","volume":"11","author":"H Mok","year":"2005","unstructured":"Mok H, Palmer DJ, Ng P, Barry MA. Evaluation of polyethylene glycol modification of first-generation and helper-dependent adenoviral vectors to reduce innate immune responses. Mol Ther. 2005;11(1):66\u201379.","journal-title":"Mol Ther."},{"issue":"7","key":"467_CR52","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1038\/mt.2008.86","volume":"16","author":"SE Hofherr","year":"2008","unstructured":"Hofherr SE, Shashkova EV, Weaver EA, Khare R, Barry MA. Modification of adenoviral vectors with polyethylene glycol modulates in vivo tissue tropism and gene expression. Mol Ther. 2008;16(7):1276\u201382.","journal-title":"Mol Ther."},{"issue":"3685","key":"467_CR53","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1126\/science.149.3685.754","volume":"149","author":"RW Atchison","year":"1965","unstructured":"Atchison RW, Casto BC, Hammon WM. Adenovirus-associated defective virus particles. Science. 1965;149(3685):754\u20136.","journal-title":"Science."},{"issue":"4","key":"467_CR54","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1128\/CMR.00008-08","volume":"21","author":"S Daya","year":"2008","unstructured":"Daya S, Berns KI. Gene therapy using adeno-associated virus vectors. Clin Microbiol Rev. 2008;21(4):583\u201393.","journal-title":"Clin Microbiol Rev."},{"issue":"6","key":"467_CR55","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/mt.2008.76","volume":"16","author":"C Zincarelli","year":"2008","unstructured":"Zincarelli C, Soltys S, Rengo G, Rabinowitz JE. Analysis of AAV serotypes 1\u20139 mediated gene expression and tropism in mice after systemic injection. Mol Ther. 2008;16(6):1073\u201380.","journal-title":"Mol Ther."},{"issue":"10","key":"467_CR56","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1089\/hum.2011.116","volume":"23","author":"ML Hillestad","year":"2012","unstructured":"Hillestad ML, Guenzel AJ, Nath KA, Barry MA. A vector\u2013host system to fingerprint virus tropism. Hum Gene Ther. 2012;23(10):1116\u201326.","journal-title":"Hum Gene Ther."},{"issue":"1","key":"467_CR57","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1038\/s41467-019-11321-7","volume":"10","author":"JF Lang","year":"2019","unstructured":"Lang JF, Toulmin SA, Brida KL, Eisenlohr LC, Davidson BL. Standard screening methods underreport AAV-mediated transduction and gene editing. Nat Commun. 2019;10(1):3415.","journal-title":"Nat Commun."},{"issue":"9","key":"467_CR58","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1681\/ASN.V1091908","volume":"10","author":"MS Lipkowitz","year":"1999","unstructured":"Lipkowitz MS, Hanss B, Tulchin N, Wilson PD, Langer JC, Ross MD, et al. Transduction of renal cells in vitro and in vivo by adeno-associated virus gene therapy vectors. J Am Soc Nephrol. 1999;10(9):1908\u201315.","journal-title":"J Am Soc Nephrol."},{"issue":"4","key":"467_CR59","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/01.ASN.0000057858.45649.F7","volume":"14","author":"S Chen","year":"2003","unstructured":"Chen S, Agarwal A, Glushakova OY, Jorgensen MS, Salgar SK, Poirier A, et al. Gene delivery in renal tubular epithelial cells using recombinant adeno-associated viral vectors. J Am Soc Nephrol. 2003;14(4):947\u201358.","journal-title":"J Am Soc Nephrol."},{"issue":"4","key":"467_CR60","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1159\/000077378","volume":"96","author":"S Takeda","year":"2004","unstructured":"Takeda S, Takahashi M, Mizukami H, Kobayashi E, Takeuchi K, Hakamata Y, et al. Successful gene transfer using adeno-associated virus vectors into the kidney: comparison among adeno-associated virus serotype 1\u20135 vectors in vitro and in vivo. Nephron Exp Nephrol. 2004;96(4):e119\u201326.","journal-title":"Nephron Exp Nephrol."},{"issue":"3","key":"467_CR61","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1464-410X.2007.07313.x","volume":"101","author":"K Ito","year":"2008","unstructured":"Ito K, Chen J, Khodadadian JJ, Vaughan ED Jr, Lipkowitz M, Poppas DP, et al. Adeno-associated viral vector transduction of green fluorescent protein in kidney: effect of unilateral ureteric obstruction. BJU Int. 2008;101(3):376\u201381.","journal-title":"BJU Int."},{"issue":"1","key":"467_CR62","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/1440-1681.12037","volume":"40","author":"YF Qi","year":"2013","unstructured":"Qi YF, Li QH, Shenoy V, Zingler M, Jun JY, Verma A, et al. Comparison of the transduction efficiency of tyrosine-mutant adeno-associated virus serotype vectors in kidney. Clin Exp Pharmacol Physiol. 2013;40(1):53\u20135.","journal-title":"Clin Exp Pharmacol Physiol."},{"issue":"1","key":"467_CR63","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000333071","volume":"1","author":"DC Chung","year":"2011","unstructured":"Chung DC, Fogelgren B, Park KM, Heidenberg J, Zuo X, Huang L, et al. Adeno-associated virus-mediated gene transfer to renal tubule cells via a retrograde ureteral approach. Nephron Extra. 2011;1(1):217\u201323.","journal-title":"Nephron Extra."},{"issue":"8","key":"467_CR64","doi-asserted-by":"publisher","first-page":"pii: e85888","DOI":"10.1172\/jci.insight.85888","volume":"1","author":"PR Konkalmatt","year":"2016","unstructured":"Konkalmatt PR, Asico LD, Zhang Y, Yang Y, Drachenberg C, Zheng X, Han F, Jose PA, Armando I. Renal rescue of dopamine D2 receptor function reverses renal injury and high blood pressure. JCI Insight. 2016;1(8):e85888. https:\/\/doi.org\/10.1172\/jci.insight.85888.","journal-title":"JCI Insight"},{"issue":"6","key":"467_CR65","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1089\/hgtb.2018.148","volume":"29","author":"X Shen","year":"2018","unstructured":"Shen X, Xu Y, Bai Z, Ma D, Niu Q, Meng J, et al. Transparenchymal renal pelvis injection of recombinant adeno-associated virus serotype 9 vectors is a practical approach for gene delivery in the kidney. Hum Gene Ther Methods. 2018;29(6):251\u20138.","journal-title":"Hum Gene Ther Methods."},{"issue":"6","key":"467_CR66","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/gt.2014.35","volume":"21","author":"CJ Rocca","year":"2014","unstructured":"Rocca CJ, Ur SN, Harrison F, Cherqui S. rAAV9 combined with renal vein injection is optimal for kidney-targeted gene delivery: conclusion of a comparative study. Gene Ther. 2014;21(6):618\u201328.","journal-title":"Gene Ther."},{"issue":"9","key":"467_CR67","doi-asserted-by":"crossref","first-page":"F1217","DOI":"10.1152\/ajprenal.00070.2013","volume":"304","author":"PR Corridon","year":"2013","unstructured":"Corridon PR, Rhodes GJ, Leonard EC, Basile DP, Gattone VH 2nd, Bacallao RL, et al. A method to facilitate and monitor expression of exogenous genes in the rat kidney using plasmid and viral vectors. Am J Physiol Ren Physiol. 2013;304(9):F1217\u201329.","journal-title":"Am J Physiol Ren Physiol."},{"issue":"12","key":"467_CR68","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s10157-019-01783-w","volume":"23","author":"S Saito","year":"2019","unstructured":"Saito S, Ohno SI, Harada Y, Oikawa K, Fujita K, Mineo S, et al. rAAV6-mediated miR-29b delivery suppresses renal fibrosis. Clin Exp Nephrol. 2019;23(12):1345\u201356.","journal-title":"Clin Exp Nephrol."},{"issue":"2","key":"467_CR69","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1172\/JCI79213","volume":"125","author":"RJ Chandler","year":"2015","unstructured":"Chandler RJ, LaFave MC, Varshney GK, Trivedi NS, Carrillo-Carrasco N, Senac JS, et al. Vector design influences hepatic genotoxicity after adeno-associated virus gene therapy. J Clin Investig. 2015;125(2):870\u201380.","journal-title":"J Clin Investig."},{"issue":"10","key":"467_CR70","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/ng.3389","volume":"47","author":"JC Nault","year":"2015","unstructured":"Nault JC, Datta S, Imbeaud S, Franconi A, Mallet M, Couchy G, et al. Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas. Nat Genet. 2015;47(10):1187\u201393.","journal-title":"Nat Genet."},{"issue":"3","key":"467_CR71","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1089\/hum.2018.015","volume":"29","author":"C Hinderer","year":"2018","unstructured":"Hinderer C, Katz N, Buza EL, Dyer C, Goode T, Bell P, et al. Severe toxicity in nonhuman primates and piglets following high-dose intravenous administration of an adeno-associated virus vector expressing human SMN. Hum Gene Ther. 2018;29(3):285\u201398.","journal-title":"Hum Gene Ther."},{"issue":"2","key":"467_CR72","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/jgm.849","volume":"8","author":"L Perabo","year":"2006","unstructured":"Perabo L, Endell J, King S, Lux K, Goldnau D, Hallek M, et al. Combinatorial engineering of a gene therapy vector: directed evolution of adeno-associated virus. J Gene Med. 2006;8(2):155\u201362.","journal-title":"J Gene Med."},{"issue":"7","key":"467_CR73","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1038\/mt.2008.100","volume":"16","author":"W Li","year":"2008","unstructured":"Li W, Asokan A, Wu Z, Van Dyke T, DiPrimio N, Johnson JS, et al. Engineering and selection of shuffled AAV genomes: a new strategy for producing targeted biological nanoparticles. Mol Ther. 2008;16(7):1252\u201360.","journal-title":"Mol Ther."},{"issue":"6","key":"467_CR74","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.celrep.2015.07.019","volume":"12","author":"E Zinn","year":"2015","unstructured":"Zinn E, Pacouret S, Khaychuk V, Turunen HT, Carvalho LS, Andres-Mateos E, et al. In silico reconstruction of the viral evolutionary lineage yields a potent gene therapy vector. Cell Rep. 2015;12(6):1056\u201368.","journal-title":"Cell Rep."},{"issue":"9","key":"467_CR75","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1681\/ASN.2018040426","volume":"29","author":"Y Ikeda","year":"2018","unstructured":"Ikeda Y, Sun Z, Ru X, Vandenberghe LH, Humphreys BD. Efficient gene transfer to kidney mesenchymal cells using a synthetic adeno-associated viral vector. J Am Soc Nephrol. 2018;29(9):2287\u201397.","journal-title":"J Am Soc Nephrol."},{"issue":"12","key":"467_CR76","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.tibtech.2015.09.008","volume":"33","author":"CJ Buchholz","year":"2015","unstructured":"Buchholz CJ, Friedel T, Buning H. Surface-engineered viral vectors for selective and cell type-specific gene delivery. Trends Biotechnol. 2015;33(12):777\u201390.","journal-title":"Trends Biotechnol."},{"issue":"5837","key":"467_CR77","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1126\/science.1142658","volume":"317","author":"A Donsante","year":"2007","unstructured":"Donsante A, Miller DG, Li Y, Vogler C, Brunt EM, Russell DW, et al. AAV vector integration sites in mouse hepatocellular carcinoma. Science. 2007;317(5837):477.","journal-title":"Science."},{"issue":"10","key":"467_CR78","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/ng.3407","volume":"47","author":"DW Russell","year":"2015","unstructured":"Russell DW, Grompe M. Adeno-associated virus finds its disease. Nat Genet. 2015;47(10):1104\u20135.","journal-title":"Nat Genet."},{"issue":"12","key":"467_CR79","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1089\/hum.2015.29014.kib","volume":"26","author":"KI Berns","year":"2015","unstructured":"Berns KI, Byrne BJ, Flotte TR, Gao G, Hauswirth WW, Herzog RW, et al. Adeno-associated virus type 2 and hepatocellular carcinoma? Hum Gene Ther. 2015;26(12):779\u201381.","journal-title":"Hum Gene Ther."},{"issue":"3","key":"467_CR80","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.ymthe.2018.01.018","volume":"26","author":"J Hordeaux","year":"2018","unstructured":"Hordeaux J, Wang Q, Katz N, Buza EL, Bell P, Wilson JM. The neurotropic properties of AAV-PHP.B are limited to C57BL\/6J mice. Mol Ther. 2018;26(3):664\u20138.","journal-title":"Mol Ther."},{"issue":"3","key":"467_CR81","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1042\/BJ20120146","volume":"443","author":"T Sakuma","year":"2012","unstructured":"Sakuma T, Barry MA, Ikeda Y. Lentiviral vectors: basic to translational. Biochem J. 2012;443(3):603\u201318.","journal-title":"Biochem J."},{"issue":"18","key":"467_CR82","doi-asserted-by":"crossref","first-page":"7306","DOI":"10.1073\/pnas.1214441110","volume":"110","author":"D Finkelshtein","year":"2013","unstructured":"Finkelshtein D, Werman A, Novick D, Barak S, Rubinstein M. LDL receptor and its family members serve as the cellular receptors for vesicular stomatitis virus. Proc Natl Acad Sci USA. 2013;110(18):7306\u201311.","journal-title":"Proc Natl Acad Sci USA."},{"issue":"17","key":"467_CR83","doi-asserted-by":"crossref","first-page":"8033","DOI":"10.1073\/pnas.90.17.8033","volume":"90","author":"JC Burns","year":"1993","unstructured":"Burns JC, Friedmann T, Driever W, Burrascano M, Yee JK. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc Natl Acad Sci USA. 1993;90(17):8033\u20137.","journal-title":"Proc Natl Acad Sci USA."},{"issue":"3","key":"467_CR84","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nm1192","volume":"11","author":"K Morizono","year":"2005","unstructured":"Morizono K, Xie Y, Ringpis GE, Johnson M, Nassanian H, Lee B, et al. Lentiviral vector retargeting to P-glycoprotein on metastatic melanoma through intravenous injection. Nat Med. 2005;11(3):346\u201352.","journal-title":"Nat Med."},{"issue":"6","key":"467_CR85","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1089\/hum.2008.189","volume":"20","author":"F Gennari","year":"2009","unstructured":"Gennari F, Lopes L, Verhoeyen E, Marasco W, Collins MK. Single-chain antibodies that target lentiviral vectors to MHC class II on antigen-presenting cells. Hum Gene Ther. 2009;20(6):554\u201362.","journal-title":"Hum Gene Ther."},{"key":"467_CR86","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3389\/fmicb.2011.00247","volume":"2","author":"T Hashiguchi","year":"2011","unstructured":"Hashiguchi T, Maenaka K, Yanagi Y. Measles virus hemagglutinin: structural insights into cell entry and measles vaccine. Front Microbiol. 2011;2:247.","journal-title":"Front Microbiol."},{"issue":"10","key":"467_CR87","doi-asserted-by":"crossref","first-page":"e46667","DOI":"10.1371\/journal.pone.0046667","volume":"7","author":"S Kneissl","year":"2012","unstructured":"Kneissl S, Abel T, Rasbach A, Brynza J, Schneider-Schaulies J, Buchholz CJ. Measles virus glycoprotein-based lentiviral targeting vectors that avoid neutralizing antibodies. PLoS One. 2012;7(10):e46667.","journal-title":"PLoS One."},{"issue":"4","key":"467_CR88","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/mt.2010.298","volume":"19","author":"RC Munch","year":"2011","unstructured":"Munch RC, Muhlebach MD, Schaser T, Kneissl S, Jost C, Pluckthun A, et al. DARPins: an efficient targeting domain for lentiviral vectors. Mol Ther. 2011;19(4):686\u201393.","journal-title":"Mol Ther."},{"issue":"5","key":"467_CR89","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.4049\/jimmunol.1500956","volume":"195","author":"Q Zhou","year":"2015","unstructured":"Zhou Q, Uhlig KM, Muth A, Kimpel J, Levy C, Munch RC, et al. Exclusive transduction of human CD4\u2009+\u2009T cells upon systemic delivery of CD4-targeted lentiviral vectors. J Immunol. 2015;195(5):2493\u2013501.","journal-title":"J Immunol."},{"issue":"1","key":"467_CR90","first-page":"49","volume":"1","author":"RJ Bosch","year":"1993","unstructured":"Bosch RJ, Woolf AS, Fine LG. Gene transfer into the mammalian kidney: direct retrovirus-transduction of regenerating tubular epithelial cells. Exp Nephrol. 1993;1(1):49\u201354.","journal-title":"Exp Nephrol"},{"issue":"3","key":"467_CR91","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1089\/10430340252792530","volume":"13","author":"GL Gusella","year":"2002","unstructured":"Gusella GL, Fedorova E, Hanss B, Marras D, Klotman ME, Klotman PE. Lentiviral gene transduction of kidney. Hum Gene Ther. 2002;13(3):407\u201314.","journal-title":"Hum Gene Ther."},{"issue":"1","key":"467_CR92","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.bbrc.2018.01.169","volume":"497","author":"LD Asico","year":"2018","unstructured":"Asico LD, Cuevas S, Ma X, Jose PA, Armando I, Konkalmatt PR. Nephron segment-specific gene expression using AAV vectors. Biochem Biophys Res Commun. 2018;497(1):19\u201324.","journal-title":"Biochem Biophys Res Commun."},{"issue":"1","key":"467_CR93","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1038\/s41467-018-05766-5","volume":"9","author":"X Xu","year":"2018","unstructured":"Xu X, Tan X, Tampe B, Wilhelmi T, Hulshoff MS, Saito S, et al. High-fidelity CRISPR\/Cas9-based gene-specific hydroxymethylation rescues gene expression and attenuates renal fibrosis. Nat Commun. 2018;9(1):3509.","journal-title":"Nat Commun."},{"key":"467_CR94","doi-asserted-by":"crossref","first-page":"16009","DOI":"10.1038\/celldisc.2016.9","volume":"2","author":"X Xu","year":"2016","unstructured":"Xu X, Tao Y, Gao X, Zhang L, Li X, Zou W, et al. A CRISPR-based approach for targeted DNA demethylation. Cell Discov. 2016;2:16009.","journal-title":"Cell Discov."},{"issue":"4","key":"467_CR95","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.stem.2017.09.006","volume":"21","author":"J Pulecio","year":"2017","unstructured":"Pulecio J, Verma N, Mejia-Ramirez E, Huangfu D, Raya A. CRISPR\/Cas9-based engineering of the epigenome. Cell Stem Cell. 2017;21(4):431\u201347.","journal-title":"Cell Stem Cell."},{"issue":"1","key":"467_CR96","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/cei.13190","volume":"194","author":"P Lavender","year":"2018","unstructured":"Lavender P, Kelly A, Hendy E, McErlean P. CRISPR-based reagents to study the influence of the epigenome on gene expression. Clin Exp Immunol. 2018;194(1):9\u201316.","journal-title":"Clin Exp Immunol."},{"issue":"8","key":"467_CR97","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/ki.2008.699","volume":"75","author":"M Kim","year":"2009","unstructured":"Kim M, Chen SW, Park SW, Kim M, D\u2019Agati VD, Yang J, et al. Kidney-specific reconstitution of the A1 adenosine receptor in A1 adenosine receptor knockout mice reduces renal ischemia-reperfusion injury. Kidney Int. 2009;75(8):809\u201323.","journal-title":"Kidney Int."},{"issue":"3","key":"467_CR98","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/labinvest.2009.143","volume":"90","author":"SW Park","year":"2010","unstructured":"Park SW, Chen SW, Kim M, D\u2019Agati VD, Lee HT. Selective intrarenal human A1 adenosine receptor overexpression reduces acute liver and kidney injury after hepatic ischemia reperfusion in mice. Lab Investig. 2010;90(3):476\u201395.","journal-title":"Lab Investig."},{"issue":"3","key":"467_CR99","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1124\/jpet.110.166884","volume":"333","author":"SW Park","year":"2010","unstructured":"Park SW, Chen SW, Kim M, Brown KM, D\u2019Agati VD, Lee HT. Protection against acute kidney injury via A(1) adenosine receptor-mediated Akt activation reduces liver injury after liver ischemia and reperfusion in mice. J Pharmacol Exp Ther. 2010;333(3):736\u201347.","journal-title":"J Pharmacol Exp Ther."},{"issue":"2","key":"467_CR100","doi-asserted-by":"crossref","first-page":"F347","DOI":"10.1152\/ajprenal.00194.2010","volume":"299","author":"M Kim","year":"2010","unstructured":"Kim M, Park SW, Kim M, Chen SW, Gerthoffer WT, D\u2019Agati VD, et al. Selective renal overexpression of human heat shock protein 27 reduces renal ischemia-reperfusion injury in mice. Am J Physiol Ren Physiol. 2010;299(2):F347\u201358.","journal-title":"Am J Physiol Ren Physiol."},{"issue":"5","key":"467_CR101","doi-asserted-by":"crossref","first-page":"11061","DOI":"10.1038\/srep11061","volume":"5","author":"J Espana-Agusti","year":"2015","unstructured":"Espana-Agusti J, Tuveson DA, Adams DJ, Matakidou A. A minimally invasive, lentiviral based method for the rapid and sustained genetic manipulation of renal tubules. Sci Rep. 2015;5(5):11061.","journal-title":"Sci Rep."},{"key":"467_CR102","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3389\/fimmu.2020.00265","volume":"11","author":"Y Yuzefovych","year":"2020","unstructured":"Yuzefovych Y, Valdivia E, Rong S, Hack F, Rother T, Schmitz J, et al. Genetic engineering of the kidney to permanently silence MHC transcripts during ex vivo organ perfusion. Front Immunol. 2020;11:265.","journal-title":"Front Immunol."},{"issue":"2","key":"467_CR103","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.virusres.2009.02.010","volume":"143","author":"A Sharma","year":"2009","unstructured":"Sharma A, Li X, Bangari DS, Mittal SK. Adenovirus receptors and their implications in gene delivery. Virus Res. 2009;143(2):184\u201394.","journal-title":"Virus Res."},{"issue":"16","key":"467_CR104","doi-asserted-by":"crossref","first-page":"7678","DOI":"10.1128\/JVI.74.16.7678-7682.2000","volume":"74","author":"V Molinier-Frenkel","year":"2000","unstructured":"Molinier-Frenkel V, Gahery-Segard H, Mehtali M, Le Boulaire C, Ribault S, Boulanger P, et al. Immune response to recombinant adenovirus in humans: capsid components from viral input are targets for vector-specific cytotoxic T lymphocytes. J Virol. 2000;74(16):7678\u201382.","journal-title":"J Virol."},{"issue":"9","key":"467_CR105","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1089\/hum.2011.002","volume":"22","author":"M Suzuki","year":"2011","unstructured":"Suzuki M, Cela R, Bertin TK, Sule G, Cerullo V, Rodgers JR, et al. NOD2 signaling contributes to the innate immune response against helper-dependent adenovirus vectors independently of MyD88 in vivo. Hum Gene Ther. 2011;22(9):1071\u201382.","journal-title":"Hum Gene Ther."},{"issue":"3","key":"467_CR106","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1089\/hum.2006.17.253","volume":"17","author":"C Baum","year":"2006","unstructured":"Baum C, Kustikova O, Modlich U, Li Z, Fehse B. Mutagenesis and oncogenesis by chromosomal insertion of gene transfer vectors. Hum Gene Ther. 2006;17(3):253\u201363.","journal-title":"Hum Gene Ther."},{"issue":"12","key":"467_CR107","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1089\/hum.2004.15.1157","volume":"15","author":"DA Muruve","year":"2004","unstructured":"Muruve DA. The innate immune response to adenovirus vectors. Hum Gene Ther. 2004;15(12):1157\u201366.","journal-title":"Hum Gene Ther."},{"issue":"4","key":"467_CR108","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1089\/hum.2016.172","volume":"28","author":"HCJ Ertl","year":"2017","unstructured":"Ertl HCJ, High KA. Impact of AAV capsid-specific T-cell responses on design and outcome of clinical gene transfer trials with recombinant adeno-associated viral vectors: an evolving controversy. Hum Gene Ther. 2017;28(4):328\u201337.","journal-title":"Hum Gene Ther."},{"issue":"3","key":"467_CR109","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1128\/JVI.71.3.1842-1849.1997","volume":"71","author":"S Hardy","year":"1997","unstructured":"Hardy S, Kitamura M, Harris-Stansil T, Dai Y, Phipps ML. Construction of adenovirus vectors through Cre\u2013lox recombination. J Virol. 1997;71(3):1842\u20139.","journal-title":"J Virol."},{"issue":"7","key":"467_CR110","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/sj.gt.3300947","volume":"6","author":"F Liu","year":"1999","unstructured":"Liu F, Song Y, Liu D. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther. 1999;6(7):1258\u201366.","journal-title":"Gene Ther."},{"issue":"1\u20133","key":"467_CR111","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0168-3659(01)00494-1","volume":"78","author":"F Liu","year":"2002","unstructured":"Liu F, Huang L. Development of non-viral vectors for systemic gene delivery. J Control Release. 2002;78(1\u20133):259\u201366.","journal-title":"J Control Release."},{"issue":"1","key":"467_CR112","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1567-5394(02)00132-9","volume":"58","author":"RI Zhdanov","year":"2002","unstructured":"Zhdanov RI, Podobed OV, Vlassov VV. Cationic lipid\u2013DNA complexes\u2013lipoplexes-for gene transfer and therapy. Bioelectrochemistry. 2002;58(1):53\u201364.","journal-title":"Bioelectrochemistry."},{"issue":"2","key":"467_CR113","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jconrel.2004.08.019","volume":"100","author":"S Zhang","year":"2004","unstructured":"Zhang S, Xu Y, Wang B, Qiao W, Liu D, Li Z. Cationic compounds used in lipoplexes and polyplexes for gene delivery. J Control Release. 2004;100(2):165\u201380.","journal-title":"J Control Release."},{"issue":"2","key":"467_CR114","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jconrel.2006.06.024","volume":"116","author":"L Wasungu","year":"2006","unstructured":"Wasungu L, Hoekstra D. Cationic lipids, lipoplexes and intracellular delivery of genes. J Control Release. 2006;116(2):255\u201364.","journal-title":"J Control Release."},{"issue":"3","key":"467_CR115","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejps.2010.03.019","volume":"40","author":"C Tros de Ilarduya","year":"2010","unstructured":"Tros de Ilarduya C, Sun Y, Duzgunes N. Gene delivery by lipoplexes and polyplexes. Eur J Pharm Sci. 2010;40(3):159\u201370.","journal-title":"Eur J Pharm Sci."},{"issue":"1","key":"467_CR116","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.biochi.2011.05.005","volume":"94","author":"XX Zhang","year":"2012","unstructured":"Zhang XX, McIntosh TJ, Grinstaff MW. Functional lipids and lipoplexes for improved gene delivery. Biochimie. 2012;94(1):42\u201358.","journal-title":"Biochimie."},{"issue":"2","key":"467_CR117","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.jconrel.2011.11.014","volume":"161","author":"C Scholz","year":"2012","unstructured":"Scholz C, Wagner E. Therapeutic plasmid DNA versus siRNA delivery: common and different tasks for synthetic carriers. J Control Release. 2012;161(2):554\u201365.","journal-title":"J Control Release."},{"issue":"1","key":"467_CR118","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0006-291X(05)80784-3","volume":"186","author":"N Tomita","year":"1992","unstructured":"Tomita N, Higaki J, Morishita R, Kato K, Mikami H, Kaneda Y, et al. Direct in vivo gene introduction into rat kidney. Biochem Biophys Res Commun. 1992;186(1):129\u201334.","journal-title":"Biochem Biophys Res Commun."},{"issue":"2","key":"467_CR119","first-page":"112","volume":"5","author":"E Imai","year":"1997","unstructured":"Imai E, Isaka Y, Akagi Y, Kaneda Y. Gene transfer into the glomerulus by the hemagglutinating virus of Japan-liposome method. Exp Nephrol. 1997;5(2):112\u20137.","journal-title":"Exp Nephrol"},{"issue":"6","key":"467_CR120","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1172\/JCI116874","volume":"92","author":"Y Isaka","year":"1993","unstructured":"Isaka Y, Fujiwara Y, Ueda N, Kaneda Y, Kamada T, Imai E. Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta or platelet-derived growth factor gene into the rat kidney. J Clin Investig. 1993;92(6):2597\u2013601.","journal-title":"J Clin Investig."},{"issue":"2","key":"467_CR121","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1046\/j.1523-1755.1999.00275.x","volume":"55","author":"Y Isaka","year":"1999","unstructured":"Isaka Y, Akagi Y, Ando Y, Tsujie M, Sudo T, Ohno N, et al. Gene therapy by transforming growth factor-beta receptor-IgG Fc chimera suppressed extracellular matrix accumulation in experimental glomerulonephritis. Kidney Int. 1999;55(2):465\u201375.","journal-title":"Kidney Int."},{"issue":"1","key":"467_CR122","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/jgm.632","volume":"7","author":"H Koike","year":"2005","unstructured":"Koike H, Tomita N, Azuma H, Taniyama Y, Yamasaki K, Kunugiza Y, et al. An efficient gene transfer method mediated by ultrasound and microbubbles into the kidney. J Gene Med. 2005;7(1):108\u201316.","journal-title":"J Gene Med."},{"issue":"11","key":"467_CR123","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1089\/hum.1996.7.11-1339","volume":"7","author":"HJ Kim","year":"1996","unstructured":"Kim HJ, Greenleaf JF, Kinnick RR, Bronk JT, Bolander ME. Ultrasound-mediated transfection of mammalian cells. Hum Gene Ther. 1996;7(11):1339\u201346.","journal-title":"Hum Gene Ther."},{"issue":"6","key":"467_CR124","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0301-5629(97)00025-2","volume":"23","author":"S Bao","year":"1997","unstructured":"Bao S, Thrall BD, Miller DL. Transfection of a reporter plasmid into cultured cells by sonoporation in vitro. Ultrasound Med Biol. 1997;23(6):953\u20139.","journal-title":"Ultrasound Med Biol."},{"issue":"7","key":"467_CR125","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/sj.gt.3300462","volume":"4","author":"U Lauer","year":"1997","unstructured":"Lauer U, Burgelt E, Squire Z, Messmer K, Hofschneider PH, Gregor M, et al. Shock wave permeabilization as a new gene transfer method. Gene Ther. 1997;4(7):710\u20135.","journal-title":"Gene Ther."},{"issue":"6","key":"467_CR126","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1023\/A:1012198321879","volume":"14","author":"JA Wyber","year":"1997","unstructured":"Wyber JA, Andrews J, D\u2019Emanuele A. The use of sonication for the efficient delivery of plasmid DNA into cells. Pharm Res. 1997;14(6):750\u20136.","journal-title":"Pharm Res."},{"issue":"9162","key":"467_CR127","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/S0140-6736(99)01244-1","volume":"353","author":"K Tachibana","year":"1999","unstructured":"Tachibana K, Uchida T, Ogawa K, Yamashita N, Tamura K. Induction of cell-membrane porosity by ultrasound. Lancet. 1999;353(9162):1409.","journal-title":"Lancet."},{"issue":"12","key":"467_CR128","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1016\/j.ultrasmedbio.2013.07.017","volume":"39","author":"AG Sorace","year":"2013","unstructured":"Sorace AG, Warram JM, Mahoney M, Zinn KR, Hoyt K. Enhancement of adenovirus delivery after ultrasound-stimulated therapy in a cancer model. Ultrasound Med Biol. 2013;39(12):2374\u201381.","journal-title":"Ultrasound Med Biol."},{"issue":"1","key":"467_CR129","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.bbrc.2009.06.020","volume":"386","author":"Y Xing","year":"2009","unstructured":"Xing Y, Pua EC, Lu X, Zhong P. Low-amplitude ultrasound enhances hydrodynamic-based gene delivery to rat kidney. Biochem Biophys Res Commun. 2009;386(1):217\u201322.","journal-title":"Biochem Biophys Res Commun."},{"issue":"8","key":"467_CR130","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/j.nano.2014.06.009","volume":"10","author":"T Kurosaki","year":"2014","unstructured":"Kurosaki T, Kawakami S, Higuchi Y, Suzuki R, Maruyama K, Sasaki H, et al. Kidney-selective gene transfection using anionic bubble lipopolyplexes with renal ultrasound irradiation in mice. Nanomedicine. 2014;10(8):1829\u201338.","journal-title":"Nanomedicine."},{"issue":"5","key":"467_CR131","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1681\/ASN.V125949","volume":"12","author":"M Tsujie","year":"2001","unstructured":"Tsujie M, Isaka Y, Nakamura H, Imai E, Hori M. Electroporation-mediated gene transfer that targets glomeruli. J Am Soc Nephrol. 2001;12(5):949\u201354.","journal-title":"J Am Soc Nephrol."},{"issue":"7","key":"467_CR132","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1172\/JCI1694","volume":"101","author":"LW Lai","year":"1998","unstructured":"Lai LW, Chan DM, Erickson RP, Hsu SJ, Lien YH. Correction of renal tubular acidosis in carbonic anhydrase II-deficient mice with gene therapy. J Clin Investig. 1998;101(7):1320\u20135.","journal-title":"J Clin Investig."},{"issue":"3","key":"467_CR133","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1089\/10430340252792585","volume":"13","author":"H Maruyama","year":"2002","unstructured":"Maruyama H, Higuchi N, Nishikawa Y, Hirahara H, Iino N, Kameda S, et al. Kidney-targeted naked DNA transfer by retrograde renal vein injection in rats. Hum Gene Ther. 2002;13(3):455\u201368.","journal-title":"Hum Gene Ther."},{"issue":"1","key":"467_CR134","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1385\/MB:27:1:23","volume":"27","author":"H Maruyama","year":"2004","unstructured":"Maruyama H, Higuchi N, Kameda S, Nakamura G, Iguchi S, Miyazaki J, et al. Rat kidney-targeted naked plasmid DNA transfer by retrograde injection into the renal vein. Mol Biotechnol. 2004;27(1):23\u201331.","journal-title":"Mol Biotechnol."},{"issue":"2","key":"467_CR135","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.bbrc.2003.12.107","volume":"314","author":"S Kameda","year":"2004","unstructured":"Kameda S, Maruyama H, Higuchi N, Iino N, Nakamura G, Miyazaki J, et al. Kidney-targeted naked DNA transfer by retrograde injection into the renal vein in mice. Biochem Biophys Res Commun. 2004;314(2):390\u20135.","journal-title":"Biochem Biophys Res Commun."},{"issue":"7","key":"467_CR136","doi-asserted-by":"crossref","first-page":"44904","DOI":"10.1038\/srep44904","volume":"20","author":"LE Woodard","year":"2017","unstructured":"Woodard LE, Cheng J, Welch RC, Williams FM, Luo W, Gewin LS, et al. Kidney-specific transposon-mediated gene transfer in vivo. Sci Rep. 2017;20(7):44904.","journal-title":"Sci Rep."},{"issue":"5","key":"467_CR137","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/jgm.300","volume":"4","author":"N Tomita","year":"2002","unstructured":"Tomita N, Morishita R, Yamamoto K, Higaki J, Dzau VJ, Ogihara T, et al. Targeted gene therapy for rat glomerulonephritis using HVJ-immunoliposomes. J Gene Med. 2002;4(5):527\u201335.","journal-title":"J Gene Med"},{"issue":"9","key":"467_CR138","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1172\/JCI127511","volume":"129","author":"M Uchida","year":"2019","unstructured":"Uchida M, Maier B, Waghwani HK, Selivanovitch E, Pay SL, Avera J, et al. The archaeal Dps nanocage targets kidney proximal tubules via glomerular filtration. J Clin Investig. 2019;129(9):3941\u201351.","journal-title":"J Clin Investig."},{"issue":"3","key":"467_CR139","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1089\/nat.2018.0721","volume":"28","author":"JA Kulkarni","year":"2018","unstructured":"Kulkarni JA, Cullis PR, van der Meel R. Lipid nanoparticles enabling gene therapies: from concepts to clinical utility. Nucleic Acid Ther. 2018;28(3):146\u201357.","journal-title":"Nucleic Acid Ther."},{"issue":"1","key":"467_CR140","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","volume":"379","author":"D Adams","year":"2018","unstructured":"Adams D, Gonzalez-Duarte A, O\u2019Riordan WD, Yang CC, Ueda M, Kristen AV, et al. Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis. N Engl J Med. 2018;379(1):11\u201321.","journal-title":"N Engl J Med."},{"issue":"11","key":"467_CR141","doi-asserted-by":"crossref","first-page":"5803","DOI":"10.1210\/en.2007-1806","volume":"149","author":"H Suga","year":"2008","unstructured":"Suga H, Nagasaki H, Kondo TA, Okajima Y, Suzuki C, Ozaki N, et al. Novel treatment for lithium-induced nephrogenic diabetes insipidus rat model using the Sendai-virus vector carrying aquaporin 2 gene. Endocrinology. 2008;149(11):5803\u201310.","journal-title":"Endocrinology."},{"key":"467_CR142","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/978-1-4939-6964-7_7","volume":"1602","author":"S Bajimaya","year":"2017","unstructured":"Bajimaya S, Hayashi T, Takimoto T. Rescue of sendai virus from cloned cDNA. Methods Mol Biol. 2017;1602:103\u201310.","journal-title":"Methods Mol Biol."},{"issue":"2","key":"467_CR143","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/path.2993","volume":"226","author":"JK Watts","year":"2012","unstructured":"Watts JK, Corey DR. Silencing disease genes in the laboratory and the clinic. J Pathol. 2012;226(2):365\u201379.","journal-title":"J Pathol."},{"issue":"17","key":"467_CR144","doi-asserted-by":"crossref","first-page":"7595","DOI":"10.1073\/pnas.88.17.7595","volume":"88","author":"S Agrawal","year":"1991","unstructured":"Agrawal S, Temsamani J, Tang JY. Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice. Proc Natl Acad Sci USA. 1991;88(17):7595\u20139.","journal-title":"Proc Natl Acad Sci USA."},{"issue":"3","key":"467_CR145","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/bdd.2510130308","volume":"13","author":"G Goodarzi","year":"1992","unstructured":"Goodarzi G, Watabe M, Watabe K. Organ distribution and stability of phosphorothioated oligodeoxyribonucleotides in mice. Biopharm Drug Dispos. 1992;13(3):221\u20137.","journal-title":"Biopharm Drug Dispos."},{"issue":"1","key":"467_CR146","first-page":"89","volume":"269","author":"PA Cossum","year":"1994","unstructured":"Cossum PA, Truong L, Owens SR, Markham PM, Shea JP, Crooke ST. Pharmacokinetics of a 14C-labeled phosphorothioate oligonucleotide, ISIS 2105, after intradermal administration to rats. J Pharmacol Exp Ther. 1994;269(1):89\u201394.","journal-title":"J Pharmacol Exp Ther."},{"issue":"4","key":"467_CR147","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/ki.1995.406","volume":"48","author":"R Oberbauer","year":"1995","unstructured":"Oberbauer R, Schreiner GF, Meyer TW. Renal uptake of an 18-mer phosphorothioate oligonucleotide. Kidney Int. 1995;48(4):1226\u201332.","journal-title":"Kidney Int."},{"issue":"5","key":"467_CR148","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1038\/ki.1995.205","volume":"47","author":"J Rappaport","year":"1995","unstructured":"Rappaport J, Hanss B, Kopp JB, Copeland TD, Bruggeman LA, Coffman TM, et al. Transport of phosphorothioate oligonucleotides in kidney: implications for molecular therapy. Kidney Int. 1995;47(5):1462\u20139.","journal-title":"Kidney Int."},{"issue":"10","key":"467_CR149","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1172\/JCI118681","volume":"97","author":"E Noiri","year":"1996","unstructured":"Noiri E, Peresleni T, Miller F, Goligorsky MS. In vivo targeting of inducible NO synthase with oligodeoxynucleotides protects rat kidney against ischemia. J Clin Investig. 1996;97(10):2377\u201383.","journal-title":"J Clin Investig."},{"issue":"1","key":"467_CR150","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ki.1996.297","volume":"50","author":"Y Akagi","year":"1996","unstructured":"Akagi Y, Isaka Y, Arai M, Kaneko T, Takenaka M, Moriyama T, et al. Inhibition of TGF-beta 1 expression by antisense oligonucleotides suppressed extracellular matrix accumulation in experimental glomerulonephritis. Kidney Int. 1996;50(1):148\u201355.","journal-title":"Kidney Int."},{"issue":"3","key":"467_CR151","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/S0002-9440(10)63478-5","volume":"163","author":"C Daniel","year":"2003","unstructured":"Daniel C, Takabatake Y, Mizui M, Isaka Y, Kawashi H, Rupprecht H, et al. Antisense oligonucleotides against thrombospondin-1 inhibit activation of TGF-beta in fibrotic renal disease in the rat in vivo. Am J Pathol. 2003;163(3):1185\u201392.","journal-title":"Am J Pathol."},{"issue":"1","key":"467_CR152","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10157-007-0459-6","volume":"11","author":"N Tomita","year":"2007","unstructured":"Tomita N, Kashihara N, Morishita R. Transcription factor decoy oligonucleotide-based therapeutic strategy for renal disease. Clin Exp Nephrol. 2007;11(1):7\u201317.","journal-title":"Clin Exp Nephrol."},{"issue":"8","key":"467_CR153","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1681\/ASN.2008111204","volume":"20","author":"BA Molitoris","year":"2009","unstructured":"Molitoris BA, Dagher PC, Sandoval RM, Campos SB, Ashush H, Fridman E, et al. siRNA targeted to p53 attenuates ischemic and cisplatin-induced acute kidney injury. J Am Soc Nephrol. 2009;20(8):1754\u201364.","journal-title":"J Am Soc Nephrol."},{"issue":"4","key":"467_CR154","doi-asserted-by":"crossref","first-page":"6424","DOI":"10.1038\/srep06424","volume":"19","author":"Y Morishita","year":"2014","unstructured":"Morishita Y, Yoshizawa H, Watanabe M, Ishibashi K, Muto S, Kusano E, et al. siRNAs targeted to Smad4 prevent renal fibrosis in vivo. Sci Rep. 2014;19(4):6424.","journal-title":"Sci Rep."},{"issue":"331","key":"467_CR155","doi-asserted-by":"crossref","first-page":"331ra39","DOI":"10.1126\/scitranslmed.aac9647","volume":"8","author":"S Alidori","year":"2016","unstructured":"Alidori S, Akhavein N, Thorek DL, Behling K, Romin Y, Queen D, et al. Targeted fibrillar nanocarbon RNAi treatment of acute kidney injury. Sci Transl Med. 2016;8(331):331ra39.","journal-title":"Sci Transl Med"},{"issue":"7","key":"467_CR156","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/mt.2010.71","volume":"18","author":"S Schievenbusch","year":"2010","unstructured":"Schievenbusch S, Strack I, Scheffler M, Nischt R, Coutelle O, Hosel M, et al. Combined paracrine and endocrine AAV9 mediated expression of hepatocyte growth factor for the treatment of renal fibrosis. Mol Ther. 2010;18(7):1302\u20139.","journal-title":"Mol Ther."},{"issue":"3","key":"467_CR157","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.kint.2017.02.017","volume":"92","author":"SJ Holditch","year":"2017","unstructured":"Holditch SJ, Schreiber CA, Harris PC, LaRusso NF, Ramirez-Alvarado M, Cataliotti A, et al. B-type natriuretic peptide overexpression ameliorates hepatorenal fibrocystic disease in a rat model of polycystic kidney disease. Kidney Int. 2017;92(3):657\u201368.","journal-title":"Kidney Int."},{"issue":"24","key":"467_CR158","doi-asserted-by":"crossref","first-page":"4132","DOI":"10.1093\/hmg\/ddz244","volume":"28","author":"SJ Holditch","year":"2019","unstructured":"Holditch SJ, Brown CN, Atwood DJ, Pokhrel D, Brown SE, Lombardi AM, et al. The consequences of increased 4E-BP1 in polycystic kidney disease. Hum Mol Genet. 2019;28(24):4132\u201347.","journal-title":"Hum Mol Genet."},{"key":"467_CR159","doi-asserted-by":"crossref","unstructured":"Wang B, Wang J, He W, Zhao Y, Zhang A, Liu Y, et al. Exogenous miR-29a attenuates muscle atrophy and kidney fibrosis in unilateral ureteral obstruction mice. Hum Gene Ther. 2020.","DOI":"10.2139\/ssrn.3411033"},{"key":"467_CR160","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.copbio.2018.01.025","volume":"53","author":"P Vormittag","year":"2018","unstructured":"Vormittag P, Gunn R, Ghorashian S, Veraitch FS. A guide to manufacturing CAR T cell therapies. Curr Opin Biotechnol. 2018;53:164\u201381.","journal-title":"Curr Opin Biotechnol."},{"issue":"2","key":"467_CR161","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1172\/JCI117361","volume":"94","author":"M Kitamura","year":"1994","unstructured":"Kitamura M, Taylor S, Unwin R, Burton S, Shimizu F, Fine LG. Gene transfer into the rat renal glomerulus via a mesangial cell vector: site-specific delivery, in situ amplification, and sustained expression of an exogenous gene in vivo. J Clin Investig. 1994;94(2):497\u2013505.","journal-title":"J Clin Investig."},{"issue":"1","key":"467_CR162","first-page":"56","volume":"4","author":"M Kitamura","year":"1996","unstructured":"Kitamura M, Burton S, Yokoo T, Fine LG. Gene delivery into the renal glomerulus by transfer of genetically engineered, autologous mesangial cells. Exp Nephrol. 1996;4(1):56\u20139.","journal-title":"Exp Nephrol"},{"issue":"3","key":"467_CR163","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF03401628","volume":"2","author":"T Naito","year":"1996","unstructured":"Naito T, Yokoyama H, Moore KJ, Dranoff G, Mulligan RC, Kelley VR. Macrophage growth factors introduced into the kidney initiate renal injury. Mol Med. 1996;2(3):297\u2013312.","journal-title":"Mol Med."},{"issue":"14","key":"467_CR164","doi-asserted-by":"crossref","first-page":"7387","DOI":"10.1073\/pnas.93.14.7387","volume":"93","author":"M Kitamura","year":"1996","unstructured":"Kitamura M. Creation of a reversible on\/off system for site-specific in vivo control of exogenous gene activity in the renal glomerulus. Proc Natl Acad Sci USA. 1996;93(14):7387\u201391.","journal-title":"Proc Natl Acad Sci USA."},{"issue":"6","key":"467_CR165","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1172\/JCI119659","volume":"100","author":"M Kitamura","year":"1997","unstructured":"Kitamura M, Kawachi H. Creation of an in vivo cytosensor using engineered mesangial cells. Automatic sensing of glomerular inflammation controls transgene activity. J Clin Investig. 1997;100(6):1394\u20139.","journal-title":"J Clin Investig"},{"issue":"12","key":"467_CR166","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1182\/blood-2009-03-213934","volume":"114","author":"K Syres","year":"2009","unstructured":"Syres K, Harrison F, Tadlock M, Jester JV, Simpson J, Roy S, et al. Successful treatment of the murine model of cystinosis using bone marrow cell transplantation. Blood. 2009;114(12):2542\u201352.","journal-title":"Blood."},{"issue":"2","key":"467_CR167","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/mt.2012.214","volume":"21","author":"F Harrison","year":"2013","unstructured":"Harrison F, Yeagy BA, Rocca CJ, Kohn DB, Salomon DR, Cherqui S. Hematopoietic stem cell gene therapy for the multisystemic lysosomal storage disorder cystinosis. Mol Ther. 2013;21(2):433\u201344.","journal-title":"Mol Ther."},{"issue":"1","key":"467_CR168","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/stem.1835","volume":"33","author":"S Naphade","year":"2015","unstructured":"Naphade S, Sharma J, Gaide Chevronnay HP, Shook MA, Yeagy BA, Rocca CJ, et al. Brief reports: lysosomal cross-correction by hematopoietic stem cell-derived macrophages via tunneling nanotubes. Stem Cells. 2015;33(1):301\u20139.","journal-title":"Stem Cells."},{"issue":"1","key":"467_CR169","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41572-018-0047-y","volume":"4","author":"C Bergmann","year":"2018","unstructured":"Bergmann C, Guay-Woodford LM, Harris PC, Horie S, Peters DJM, Torres VE. Polycystic kidney disease. Nat Rev Dis Prim. 2018;4(1):50.","journal-title":"Nat Rev Dis Prim"},{"issue":"2","key":"467_CR170","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/ng1097-171","volume":"17","author":"DB Simon","year":"1997","unstructured":"Simon DB, Bindra RS, Mansfield TA, Nelson-Williams C, Mendonca E, Stone R, et al. Mutations in the chloride channel gene, CLCNKB, cause Bartter\u2019s syndrome type III. Nat Genet. 1997;17(2):171\u20138.","journal-title":"Nat Genet."},{"issue":"8","key":"467_CR171","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1681\/ASN.V1181449","volume":"11","author":"M Konrad","year":"2000","unstructured":"Konrad M, Vollmer M, Lemmink HH, van den Heuvel LP, Jeck N, Vargas-Poussou R, et al. Mutations in the chloride channel gene CLCNKB as a cause of classic Bartter syndrome. J Am Soc Nephrol. 2000;11(8):1449\u201359.","journal-title":"J Am Soc Nephrol."},{"issue":"3","key":"467_CR172","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/ng752","volume":"29","author":"R Birkenhager","year":"2001","unstructured":"Birkenhager R, Otto E, Schurmann MJ, Vollmer M, Ruf EM, Maier-Lutz I, et al. Mutation of BSND causes Bartter syndrome with sensorineural deafness and kidney failure. Nat Genet. 2001;29(3):310\u20134.","journal-title":"Nat Genet."},{"issue":"8","key":"467_CR173","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s00467-007-0468-4","volume":"22","author":"K Nozu","year":"2007","unstructured":"Nozu K, Fu XJ, Kaito H, Kanda K, Yokoyama N, Krol RP, et al. A novel mutation in KCNJ1 in a Bartter syndrome case diagnosed as pseudohypoaldosteronism. Pediatr Nephrol. 2007;22(8):1219\u201323.","journal-title":"Pediatr Nephrol."},{"issue":"2","key":"467_CR174","doi-asserted-by":"crossref","first-page":"581","DOI":"10.3892\/mmr.2016.6063","volume":"15","author":"M Sun","year":"2017","unstructured":"Sun M, Ning J, Xu W, Zhang H, Zhao K, Li W, et al. Genetic heterogeneity in patients with Bartter syndrome type 1. Mol Med Rep. 2017;15(2):581\u201390.","journal-title":"Mol Med Rep."},{"issue":"8","key":"467_CR175","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1681\/ASN.2016101057","volume":"28","author":"E Seys","year":"2017","unstructured":"Seys E, Andrini O, Keck M, Mansour-Hendili L, Courand PY, Simian C, et al. Clinical and genetic spectrum of bartter syndrome type 3. J Am Soc Nephrol. 2017;28(8):2540\u201352.","journal-title":"J Am Soc Nephrol."},{"issue":"2","key":"467_CR176","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1055\/s-0036-1579757","volume":"5","author":"JJ Findeis-Hosey","year":"2016","unstructured":"Findeis-Hosey JJ, McMahon KQ, Findeis SK. Von Hippel\u2013Lindau disease. J Pediatr Genet. 2016;5(2):116\u201323.","journal-title":"J Pediatr Genet."},{"issue":"4","key":"467_CR177","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s11255-010-9850-4","volume":"42","author":"R Enriquez","year":"2010","unstructured":"Enriquez R, Adam V, Sirvent AE, Garcia-Garcia AB, Millan I, Amoros F. Gitelman syndrome due to p.A204T mutation in CLCNKB gene. Int Urol Nephrol. 2010;42(4):1099\u2013102.","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"467_CR178","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3346\/jkms.2016.31.1.47","volume":"31","author":"JW Lee","year":"2016","unstructured":"Lee JW, Lee J, Heo NJ, Cheong HI, Han JS. Mutations in SLC12A3 and CLCNKB and their correlation with clinical phenotype in patients with Gitelman and Gitelman-like Syndrome. J Korean Med Sci. 2016;31(1):47\u201354.","journal-title":"J Korean Med Sci."},{"issue":"1","key":"467_CR179","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.kint.2016.09.046","volume":"91","author":"A Blanchard","year":"2017","unstructured":"Blanchard A, Bockenhauer D, Bolignano D, Calo LA, Cosyns E, Devuyst O, et al. Gitelman syndrome: consensus and guidance from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2017;91(1):24\u201333.","journal-title":"Kidney Int."},{"issue":"1","key":"467_CR180","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12887-019-1498-3","volume":"19","author":"Y Kong","year":"2019","unstructured":"Kong Y, Xu K, Yuan K, Zhu J, Gu W, Liang L, et al. Digenetic inheritance of SLC12A3 and CLCNKB genes in a Chinese girl with Gitelman syndrome. BMC Pediatr. 2019;19(1):114.","journal-title":"BMC Pediatr."},{"issue":"3","key":"467_CR181","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1046\/j.1523-1755.2000.00254.x","volume":"58","author":"J Patrakka","year":"2000","unstructured":"Patrakka J, Kestila M, Wartiovaara J, Ruotsalainen V, Tissari P, Lenkkeri U, et al. Congenital nephrotic syndrome (NPHS1): features resulting from different mutations in Finnish patients. Kidney Int. 2000;58(3):972\u201380.","journal-title":"Kidney Int."},{"issue":"9","key":"467_CR182","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1359\/jbmr.1999.14.9.1536","volume":"14","author":"JP Cox","year":"1999","unstructured":"Cox JP, Yamamoto K, Christie PT, Wooding C, Feest T, Flinter FA, et al. Renal chloride channel, CLCN5, mutations in Dent\u2019s disease. J Bone Miner Res. 1999;14(9):1536\u201342.","journal-title":"J Bone Miner Res."},{"issue":"3","key":"467_CR183","doi-asserted-by":"crossref","first-page":"e1000870","DOI":"10.1371\/journal.pgen.1000870","volume":"6","author":"RP Alur","year":"2010","unstructured":"Alur RP, Vijayasarathy C, Brown JD, Mehtani M, Onojafe IF, Sergeev YV, et al. Papillorenal syndrome-causing missense mutations in PAX2\/Pax2 result in hypomorphic alleles in mouse and human. PLoS Genet. 2010;6(3):e1000870.","journal-title":"PLoS Genet."},{"issue":"3","key":"467_CR184","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nrneph.2012.259","volume":"9","author":"J Kruegel","year":"2013","unstructured":"Kruegel J, Rubel D, Gross O. Alport syndrome\u2013insights from basic and clinical research. Nat Rev Nephrol. 2013;9(3):170\u20138.","journal-title":"Nat Rev Nephrol."},{"issue":"11","key":"467_CR185","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13023-016-0426-y","volume":"22","author":"MA Elmonem","year":"2016","unstructured":"Elmonem MA, Veys KR, Soliman NA, van Dyck M, van den Heuvel LP, Levtchenko E. Cystinosis: a review. Orphanet J Rare Dis. 2016;22(11):47.","journal-title":"Orphanet J Rare Dis."},{"key":"467_CR186","doi-asserted-by":"crossref","unstructured":"Tetti M, Monticone S, Burrello J, Matarazzo P, Veglio F, Pasini B, et al. Liddle Syndrome: review of the literature and description of a new case. Int J Mol Sci. 2018;19(3).","DOI":"10.3390\/ijms19030812"},{"issue":"4","key":"467_CR187","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1053\/j.ajkd.2017.08.024","volume":"71","author":"SM Yu","year":"2018","unstructured":"Yu SM, Bleyer AJ, Anis K, Herlitz L, Zivna M, Hulkova H, et al. Autosomal dominant tubulointerstitial kidney disease due to MUC1 mutation. Am J Kidney Dis. 2018;71(4):495\u2013500.","journal-title":"Am J Kidney Dis."},{"issue":"1","key":"467_CR188","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1186\/s12882-018-1107-y","volume":"19","author":"C Gast","year":"2018","unstructured":"Gast C, Marinaki A, Arenas-Hernandez M, Campbell S, Seaby EG, Pengelly RJ, et al. Autosomal dominant tubulointerstitial kidney disease-UMOD is the most frequent non polycystic genetic kidney disease. BMC Nephrol. 2018;19(1):301.","journal-title":"BMC Nephrol."},{"issue":"1","key":"467_CR189","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s12882-017-0631-5","volume":"18","author":"RL Clissold","year":"2017","unstructured":"Clissold RL, Clarke HC, Spasic-Boskovic O, Brugger K, Abbs S, Bingham C, et al. Discovery of a novel dominant mutation in the REN gene after forty years of renal disease: a case report. BMC Nephrol. 2017;18(1):234.","journal-title":"BMC Nephrol."},{"issue":"1","key":"467_CR190","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41572-019-0109-9","volume":"5","author":"O Devuyst","year":"2019","unstructured":"Devuyst O, Olinger E, Weber S, Eckardt KU, Kmoch S, Rampoldi L, et al. Autosomal dominant tubulointerstitial kidney disease. Nat Rev Dis Primers. 2019;5(1):60.","journal-title":"Nat Rev Dis Primers."},{"issue":"1","key":"467_CR191","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.1038\/s41467-019-11918-y","volume":"10","author":"EC Lee","year":"2019","unstructured":"Lee EC, Valencia T, Allerson C, Schairer A, Flaten A, Yheskel M, et al. Discovery and preclinical evaluation of anti-miR-17 oligonucleotide RGLS4326 for the treatment of polycystic kidney disease. Nat Commun. 2019;10(1):4148.","journal-title":"Nat Commun."},{"key":"467_CR192","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/978-1-4939-9065-8_14","volume":"1937","author":"CJ Rocca","year":"2019","unstructured":"Rocca CJ, Cherqui S. Gene transfer to mouse kidney in vivo. Methods Mol Biol. 2019;1937:227\u201334.","journal-title":"Methods Mol Biol."},{"issue":"10","key":"467_CR193","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s00467-005-1882-0","volume":"20","author":"M Jerebtsova","year":"2005","unstructured":"Jerebtsova M, Liu XH, Ye X, Ray PE. Adenovirus-mediated gene transfer to glomerular cells in newborn mice. Pediatr Nephrol. 2005;20(10):1395\u2013400.","journal-title":"Pediatr Nephrol."}],"container-title":["Molecular Diagnosis &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-020-00467-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40291-020-00467-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-020-00467-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T06:08:18Z","timestamp":1696054098000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40291-020-00467-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,22]]},"references-count":193,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["467"],"URL":"https:\/\/doi.org\/10.1007\/s40291-020-00467-6","relation":{},"ISSN":["1177-1062","1179-2000"],"issn-type":[{"value":"1177-1062","type":"print"},{"value":"1179-2000","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,22]]},"assertion":[{"value":"22 April 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"This work was supported by the Department of Molecular Medicine at Mayo Clinic (J.D.R.), National Institute of Diabetes Digestive and Kidney Diseases Grant number 1F31DK123858\u201301 and P30-DK090728 (J.D.R.), and the Department of Laboratory Medicine and Pathology at Mayo Clinic (M.A.B.).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Jeffrey D. Rubin and Michael A. Barry have no conflicts of interest that are directly relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}